Tien Liang Biotech Co., Ltd.(TW:4127)
NT$36.150.00 (0.00%)
TW:4127
Tien Liang Biotech Co., Ltd. Revenue
NT$36.15
At close:0.00 (0.00%)
Tien Liang Biotech Co., Ltd. (4127) Revenue
Tien Liang Biotech Co., Ltd. Revenue
Tien Liang Biotech Co., Ltd. had a revenue of 184.74M in the quarter ending Jun 30, 2026, with -6.83%. This bring the company's revenue in the last twelve months to 650.87M, Increased 9.67%. In the fiscal year ending Dec 31, 2025, Tien Liang Biotech Co., Ltd. had annual revenue of 511.79M with 32.86% growth.
- Revenue (ttm)
- 650.87M
- Revenue Growth
- 52.12%
- P/S Ratio
- 3.23
- Revenue/Employee
- TWD 5,815,830
- Employees
- 88
- Market Cap
- TWD 1.65B
Revenue Chart
Tien Liang Biotech Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 511.79M | 126.59M | 32.86% |
| Dec 31, 2024 | 385.21M | -74.79M | -16.26% |
| Dec 31, 2023 | 459.99M | -68.53M | -12.97% |
| Dec 31, 2022 | 528.52M | -42.79M | -7.49% |
| Dec 31, 2021 | 571.32M | 140.23M | 32.53% |
| Dec 31, 2020 | 431.08M | -4.78M | -1.10% |
| Dec 31, 2019 | 435.86M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.